Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Therapeutic Drug Monitoring
|
June 1, 1997
Special considerations for monitoring vancomycin concentrations in pediatric patients
M V Miles, L Li, H Lakkis, et al.
Clinical Chemistry
|
February 13, 2001
HPLC analysis of reduced and oxidized coenzyme Q(10) in human plasma
P H Tang, M V Miles, A DeGrauw, et al.
Therapeutic Drug Monitoring
|
April 1, 1996
Development of a fluorescence polarization immunoassay for lorazepam quantification
P G Agbuya, L Li, M V Miles, et al.
Epilepsia
|
May 1, 1989
Effects of enteral tube feeding on the absorption and pharmacokinetic profile of carbamazepine suspension
J Bass, M V Miles, M B Tennison, et al.
The American Journal of Physiology
|
April 1, 1992
Increased serum clearance and degradation of 125I-labeled IGF-I in protein-restricted rats
J P Thissen, M L Davenport, J B Pucilowska, et al.
Epilepsia
|
September 1, 1988
Valproate metabolites and hepatotoxicity in an epileptic population
M B Tennison, M V Miles, G M Pollack, et al.
Epilepsia
|
June 15, 1999
Topiramate pharmacokinetics in infants
T A Glauser, M V Miles, P Tang, et al.
Pediatrics
|
August 1, 1990
Rapid loading of critically ill patients with carbamazepine suspension
M V Miles, S T Lawless, M B Tennison, et al.
Therapeutic Drug Monitoring
|
January 1, 1989
Determination of N-desmethylmethsuximide serum concentrations using enzyme-multiplied and fluorescence polarization immunoassays
M V Miles, C M Howlett, M B Tennison, et al.
Endocrinology
|
September 1, 1990
Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy
M L Davenport, D R Clemmons, M V Miles, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Therapeutic Drug Monitoring
|
June 1, 1997
Special considerations for monitoring vancomycin concentrations in pediatric patients
M V Miles, L Li, H Lakkis, et al.
Clinical Chemistry
|
February 13, 2001
HPLC analysis of reduced and oxidized coenzyme Q(10) in human plasma
P H Tang, M V Miles, A DeGrauw, et al.
Therapeutic Drug Monitoring
|
April 1, 1996
Development of a fluorescence polarization immunoassay for lorazepam quantification
P G Agbuya, L Li, M V Miles, et al.
Epilepsia
|
May 1, 1989
Effects of enteral tube feeding on the absorption and pharmacokinetic profile of carbamazepine suspension
J Bass, M V Miles, M B Tennison, et al.
The American Journal of Physiology
|
April 1, 1992
Increased serum clearance and degradation of 125I-labeled IGF-I in protein-restricted rats
J P Thissen, M L Davenport, J B Pucilowska, et al.
Epilepsia
|
September 1, 1988
Valproate metabolites and hepatotoxicity in an epileptic population
M B Tennison, M V Miles, G M Pollack, et al.
Epilepsia
|
June 15, 1999
Topiramate pharmacokinetics in infants
T A Glauser, M V Miles, P Tang, et al.
Pediatrics
|
August 1, 1990
Rapid loading of critically ill patients with carbamazepine suspension
M V Miles, S T Lawless, M B Tennison, et al.
Therapeutic Drug Monitoring
|
January 1, 1989
Determination of N-desmethylmethsuximide serum concentrations using enzyme-multiplied and fluorescence polarization immunoassays
M V Miles, C M Howlett, M B Tennison, et al.
Endocrinology
|
September 1, 1990
Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy
M L Davenport, D R Clemmons, M V Miles, et al.
Page
of 3